elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26746194-0698A674-C9E0-433B-B092-53446C895AF2
Q26746194-0698A674-C9E0-433B-B092-53446C895AF2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26746194-0698A674-C9E0-433B-B092-53446C895AF2
Anti-nerve growth factor in pain management: current evidence
P2860
Q26746194-0698A674-C9E0-433B-B092-53446C895AF2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26746194-0698A674-C9E0-433B-B092-53446C895AF2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3aebdbfb1081bef94ebb46823a06cbef2f566395
P2860
Fasinumab (REGN475), an antinerve growth factor monoclonal antibody, for the treatment of acute sciatic pain: results of a proof-of-concept study